MedValue is powered by the Radboudumc in Nijmegen.At MedValue we believe that medical innovations are indispensable for maintaining the future of healthcare. At the same time, we know that the road from innovative solution to successful market product is full of pitfalls. A good idea is only the beginning because, without a powerful business case, solutions can become stranded in the concept phase. This is why MedValue helps businesses to substantiate the added value of their innovations. By using our products, we ensure overview, create focus, map the needs of various stakeholders and analyse the potential value and cost-effectiveness of an innovation. With our integrated approach, we help our clients to increase the impact of a medical innovation.

Performing and supervising (early) Health Technology Assessments for the healthcare industry. Early assessment of technologies gives healthcare companies insight in the potential added value of their products with respect to health gain and cost-effectiveness. With this information companies can reduce their financial risks and improve their impact and profits by maximizing the value of their products for patients and other interested parties. Also involved in product development within the Health Technology Assessment methodology to be able to provide the most relevant information in all stages of product development.

Health Technology Assessment in the field of Head and Neck Cancer. Assessing treatment strategies / new procedures on (cost-)effectiveness both on population and individual level. My main focus is the use of decision analytical modelling to combine relevant information around new healthcare technologies to inform stakeholders about the consquences of these innovations. This information can be used in clinical decision making but also to inform future steps in research and development.Finished PhD: A modeling approach to evidence-based treatment decisions: Surgical management of the neck in patients with oral cancer